PMID- 18728784 OWN - NLM STAT- MEDLINE DCOM- 20081218 LR - 20211020 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 3 IP - 8 DP - 2008 Aug 27 TI - Synthetic activation of endogenous PI3K and Rac identifies an AND-gate switch for cell polarization and migration. PG - e3068 LID - 10.1371/journal.pone.0003068 [doi] LID - e3068 AB - Phosphatidylinositol 3-OH kinase (PI3K) has been widely studied as a principal regulator of cell polarization, migration, and chemotaxis. Surprisingly, recent studies showed that mammalian neutrophils and Dictyostelium discoideum cells can polarize and migrate in the absence of PI3K activity. Here we directly probe the roles of PI3K and its downstream effector, Rac, in HL-60 neutrophils by using a chemical biology approach whereby the endogenously present enzymes are synthetically activated in less than one minute. We show that uniform activation of endogenous PI3K is sufficient to polarize previously unpolarized neutrophils and trigger effective cell migration. After a delay following symmetrical phosphatidylinositol (3,4,5)-triphosphate (PIP(3)) production, a polarized distribution of PIP(3) was induced by positive feedback requiring actin polymerization. Pharmacological studies argue that this process does not require receptor-coupled trimeric G proteins. Contrary to the current working model, rapid activation of endogenous Rac proteins triggered effective actin polymerization but failed to feed back to PI3K to generate PIP(3) or induce cell polarization. Thus, the increase in PIP(3) concentration at the leading edge is generated by positive feedback with an AND gate logic with a PI3K-Rac-actin polymerization pathway as a first input and a PI3K initiated non-Rac pathway as a second input. This AND-gate control for cell polarization can explain how Rac can be employed for both PI3K-dependent and -independent signaling pathways coexisting in the same cell. FAU - Inoue, Takanari AU - Inoue T AD - Chemical and Systems Biology, Bio-X Program, Stanford University, Stanford, California, USA. FAU - Meyer, Tobias AU - Meyer T LA - eng GR - R01 GM063702/GM/NIGMS NIH HHS/United States GR - PN2 EY1018241/EY/NEI NIH HHS/United States GR - GM063702/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20080827 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Actins) RN - 0 (Bacterial Proteins) RN - 0 (Luminescent Proteins) RN - 0 (yellow fluorescent protein, Bacteria) RN - 59880-97-6 (N-Formylmethionine Leucyl-Phenylalanine) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 3.6.1.- (GTP-Binding Proteins) SB - IM MH - Actins/metabolism MH - Bacterial Proteins/genetics MH - Cell Movement/physiology MH - Cell Polarity/physiology MH - Chemotaxis/physiology MH - Enzyme Activation MH - GTP-Binding Proteins/physiology MH - HL-60 Cells MH - Humans MH - Luminescent Proteins/genetics MH - N-Formylmethionine Leucyl-Phenylalanine/pharmacology MH - Neutrophils/enzymology/physiology MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Proto-Oncogene Proteins c-akt/*metabolism MH - Signal Transduction MH - Transfection PMC - PMC2518103 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2008/08/30 09:00 MHDA- 2008/12/19 09:00 PMCR- 2008/08/27 CRDT- 2008/08/30 09:00 PHST- 2008/05/11 00:00 [received] PHST- 2008/07/17 00:00 [accepted] PHST- 2008/08/30 09:00 [pubmed] PHST- 2008/12/19 09:00 [medline] PHST- 2008/08/30 09:00 [entrez] PHST- 2008/08/27 00:00 [pmc-release] AID - 08-PONE-RA-04658R1 [pii] AID - 10.1371/journal.pone.0003068 [doi] PST - epublish SO - PLoS One. 2008 Aug 27;3(8):e3068. doi: 10.1371/journal.pone.0003068.